Key result
Positive enterovirus PCR identifies 0% prevalence of invasive bacterial infection in young febrile infants.
Why the study?
The impact of blood enterovirus and human parechovirus PCR testing in young infants with fever without a source had not been well analysed.
Does a positive blood ev-PCR test identify a lower risk of invasive bacterial infection in young infants ≤90 days of age with fever without a source?
Observational (n=703)
Does a positive blood ev-PCR test identify a lower risk of invasive bacterial infection in young infants ≤90 days of age with fever without a source?
A positive blood enterovirus PCR test in young febrile infants identifies a group at very low risk for invasive bacterial infection, which may help reduce unnecessary hospitalizations and antibiotic use.
Answers are grounded in this paper and cite their sources.
May support risk stratification in febrile infants; leaves open whether PCR testing should alter management without prospective validation.
OBJECTIVE: To analyse the impact of blood enterovirus and human parechovirus PCR (ev-PCR) testing in young infants with fever without a source (FWS). DESIGN: Observational study, subanalysis of a prospective registry. SETTING: Paediatric emergency department. PATIENTS: Infants ≤90 days of age with FWS seen between September 2015 and August 2019 with blood ev-PCR, blood and urine cultures and urine dipstick test performed. MAIN OUTCOME MEASURES: Prevalence of invasive bacterial infection (IBI: bacterial pathogen in blood or cerebrospinal fluid) in infants with positive or negative ev-PCR test results. Secondarily, we also compared length of stay and antibiotic treatment in hospitalised infants. RESULTS: Of 703 infants, 174 (24.7%) had a positive blood ev-PCR and none of them were diagnosed with an IBI (vs 2.6% (95% CI 1.3% to 4.0%) of those with a negative result, p=0.02). Prevalence of non-IBI (mainly urinary tract infection) was also lower among infants with a positive blood ev-PCR (2.3% (95% CI 0.1% to 4.5%) vs 17.6% (95% CI 14.3% to 20.8%), p<0.01).Overall, 258 infants were hospitalised (36.6%) and 193 (74.8%) of them received antibiotics. Length of hospital stay and antibiotic treatment were shorter in those with a positive blood ev-PCR (median: 3 days vs 5 days and 1 day vs 5 days, respectively; p<0.01). Differences remained statistically significant among well-appearing infants >21 days old with normal urine dipstick. CONCLUSION: Blood ev-PCR identifies a group of infants under 90 days of age with FWS at very low risk of IBI. This test may help to guide clinical decision making in young febrile infants.
No takes yet. Share an insight, caveat, or question.
Pintos et al. (2021) conducted an observational in Fever without a source (FWS) (n=703). Positive blood enterovirus and human parechovirus PCR (ev-PCR) test vs. Negative blood ev-PCR test was evaluated on Prevalence of invasive bacterial infection (IBI) (p=0.02). Positive blood enterovirus PCR testing in infants ≤90 days with fever without a source identified a 0% prevalence of invasive bacterial infection compared to 2.6% with a negative test.
Synapse has enriched 10 related papers. Consider them for comparative context: